Treatment with anti-PD-L1 antibodies reduced tumor growth in the treated mice by 50% compared with the controls (Supplementary Figure 14a), indicating that this model is less sensitive to immunotherapy with PD-L1 blockers compared with the MC38 cell line. This evidence concerns the gene CD274 and neoplasm.